3 research outputs found

    DIVERSIDADE GENÉTICA:: PACIENTES QUIMÉRICOS E SEU IMPACTO NA SAÚDE PÚBLICA

    Get PDF
    Quimerismo é uma condição rara proporcionada pelo comportamento imprevisível do genoma humano, caracterizado pela incomum presença de mais de um material genético em um único indivíduo. Devido à existência desse duplo DNA, a vítima possui maiores chances de desenvolver doenças genéticas, cujo diagnóstico correto se torna um desafio para a equipe de saúde. Desse modo, objetivando avaliar o atendimento de pacientes quimeras em instituições de saúde e o desempenho profissional em lidar com essa situação, o grupo realizou uma revisão na literatura de trabalhos, ou registro de casos a partir da década de noventa nos buscadores científicos Google Schoolar, PubMed, Scielo e Portal de Periódicos Capes de pacientes quimeras que procuraram ajuda médica para a patologia manifestada e obtiveram diferentes diagnósticos para seu problema. Notou-se que, em casos antigos, o índice de diagnósticos ineficazes para o grupo supracitado era maior. Entretanto, com o passar do tempo e com o avançar dos estudos e do aconselhamento genético, percebeu-se uma melhora na qualidade e velocidade em detectar a condição de quimera, oferecendo tratamentos mais adequados à vítima, como também, reparou-se que em profissionais especializados na área genética tinham melhor atendimento, apesar de que ainda há uma necessidade de investimentos para o atendimento de indivíduos com distintas condições genéticas. Portanto, visto a complexidade da genética e a presença de patologias relacionadas a ela, é vital que haja diagnósticos eficientes e melhor desempenho profissional em analisá-los

    An evidence-informed policymaking (EIPM) competency profile for the Brazilian Health System developed through consensus: process and outcomes

    Get PDF
    Abstract Background Evidence-informed policymaking (EIPM) requires a set of individual and organizational knowledge, skills and attitudes that should be articulated with background factors and needs. In this regard, the development of an EIPM competency profile is important to support the diagnosis, planning and implementation of EIPM. Purpose To present the process and outcomes of the development of an EIPM competency profile by an expert committee, to be applied in different contexts of the Brazilian Health System. Methods A committee of experts in EIPM shared different views, experiences and opinions to develop an EIPM competency profile for Brazil. In six consensus workshops mediated by facilitators, the committee defined from macro problems to key actions and performances essential for the competency profile. The development steps consisted of: (1) Constitution of the committee, including researchers, professionals with practical experience, managers, and educators; (2) Development of a rapid review on EIPM competency profiles; (3) Agreement on commitments and responsibilities in the processes; (4) Identification and definition of macro problems relating to the scope of the competency profile; and (5) Outlining of general and specific capacities, to be incorporated into the competency profile, categorized by key actions. Results The development of the EIPM competency profile was guided by the following macro problems: (1) lack of systematic and transparent decision-making processes in health policy management; (2) underdeveloped institutional capacity for knowledge management and translation; and (3) incipient use of scientific evidence in the formulation and implementation of health policies. A general framework of key actions and performances of the EIPM Competency Profile for Brazil was developed, including 42 specific and general key actions distributed by area of activity (Health Management, Scientific Research, Civil Society, Knowledge Translation, and Cross-sectional areas). Conclusions The competency profile presented in this article can be used in different contexts as a key tool for the institutionalization of EIPM

    Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies

    No full text
    Background: Geoeconomic variations in epidemiology, the practice of ventilation, and outcome in invasively ventilated intensive care unit (ICU) patients without acute respiratory distress syndrome (ARDS) remain unexplored. In this analysis we aim to address these gaps using individual patient data of four large observational studies. Methods: In this pooled analysis we harmonised individual patient data from the ERICC, LUNG SAFE, PRoVENT, and PRoVENT-iMiC prospective observational studies, which were conducted from June, 2011, to December, 2018, in 534 ICUs in 54 countries. We used the 2016 World Bank classification to define two geoeconomic regions: middle-income countries (MICs) and high-income countries (HICs). ARDS was defined according to the Berlin criteria. Descriptive statistics were used to compare patients in MICs versus HICs. The primary outcome was the use of low tidal volume ventilation (LTVV) for the first 3 days of mechanical ventilation. Secondary outcomes were key ventilation parameters (tidal volume size, positive end-expiratory pressure, fraction of inspired oxygen, peak pressure, plateau pressure, driving pressure, and respiratory rate), patient characteristics, the risk for and actual development of acute respiratory distress syndrome after the first day of ventilation, duration of ventilation, ICU length of stay, and ICU mortality. Findings: Of the 7608 patients included in the original studies, this analysis included 3852 patients without ARDS, of whom 2345 were from MICs and 1507 were from HICs. Patients in MICs were younger, shorter and with a slightly lower body-mass index, more often had diabetes and active cancer, but less often chronic obstructive pulmonary disease and heart failure than patients from HICs. Sequential organ failure assessment scores were similar in MICs and HICs. Use of LTVV in MICs and HICs was comparable (42·4% vs 44·2%; absolute difference -1·69 [-9·58 to 6·11] p=0·67; data available in 3174 [82%] of 3852 patients). The median applied positive end expiratory pressure was lower in MICs than in HICs (5 [IQR 5-8] vs 6 [5-8] cm H2O; p=0·0011). ICU mortality was higher in MICs than in HICs (30·5% vs 19·9%; p=0·0004; adjusted effect 16·41% [95% CI 9·52-23·52]; p<0·0001) and was inversely associated with gross domestic product (adjusted odds ratio for a US$10 000 increase per capita 0·80 [95% CI 0·75-0·86]; p<0·0001). Interpretation: Despite similar disease severity and ventilation management, ICU mortality in patients without ARDS is higher in MICs than in HICs, with a strong association with country-level economic status
    corecore